Are you a print subscriber? Activate your account. By Tim Nudd - 1 hour 14 min ago By Adrianne Pasquarelli - 5 hours 42 min ago By Erika Wheless - 5 hours 42 min ago By Brian Bonilla - 5 hours 42 ...
...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this ...
When a novel coronavirus struck in early 2020, Pfizer’sPFE-1.18%decrease; red down pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...
Long-sleeved T-shirts are an underrated wardrobe staple. As stylist and fashion designer Jordan Page of @veryadvanced points out, the humble long-sleeved tee can look “classier than short ...
WICHITA, Kan. (KSNW) – The Pfizer plant in McPherson laid off 80 people, KSN News confirmed on Thursday. Those impacted included professional/salaried employees, and production was not impacted.
Guggenheim has earned $172 million from advising Pfizer on nearly $400 billion in acquisitions since 2011. Pfizer’s stock has dropped over 50% since its pandemic peak, following a series of ...
Pfizer offers a generous 5.73% dividend yield. The stock is trading at an attractive forward P/E of 9.5x 2026 earnings. The company has multiple potential growth drivers in its pipeline. Pfizer's ...
“We are fully supportive of Pfizer chairman & CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value,” the pair said in the ...
In this case, I was visiting my grandparents. And what I forgot was T-shirts. Yes, I forgot to pack an entire category of clothing. Not long after my arrival, I bought an emergency T-shirt from a ...
Pfizer is deepening its investment in protein degraders through a new partnership with Triana Biomedicines, a startup working in the trendy field of molecular ...
(Bloomberg) -- Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an ...
Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on the action. Pfizer is laying out $49 million upfront in a partnership ...